Role of Pratimarsha Nasya in Recurrent Upper Respiratory Infections: A Critical Integrative Review
Abstract
Recurrent upper respiratory infections (URIs) constitute a significant clinical burden, particularly in pediatric populations,
leading to repeated morbidity, antibiotic use, and healthcare utilization. Conventional management primarily focuses on
symptomatic relief, prevention, and addressing underlying risk factors; however, recurrence remains a persistent challenge.
In Ayurveda, Pratimarsha Nasya, a form of daily nasal administration of medicated oils or ghee in small doses, is described
as a preventive and therapeutic modality for disorders involving the head and neck region. This review critically evaluates
the role of Pratimarsha Nasya in the prevention and management of recurrent URIs, correlating classical Ayurvedic
principles with modern concepts of mucosal immunity and respiratory defense mechanisms. A structured literature review
was conducted using classical texts (Charaka Samhita, Sushruta Samhita, Ashtanga Hridaya) and modern databases
including PubMed, Scopus, and Web of Science. Evidence suggests that Pratimarsha Nasya may enhance local immunity,
improve mucociliary clearance, and maintain nasal mucosal integrity. Medicated oils such as Anu Taila and Shadbindu
Taila are traditionally indicated. Modern studies on nasal oil application indicate potential benefits in reducing pathogen
adherence and inflammation, although robust clinical trials are limited. While Ayurvedic descriptions emphasize daily
preventive use without significant adverse effects, contemporary evidence remains insufficient for definitive conclusions.
Integrative approaches combining Pratimarsha Nasya with standard preventive strategies may offer a promising avenue
for reducing URI recurrence, warranting further scientific validation
Keywords
Pratimarsha Nasya, recurrent upper respiratory infections, Ayurveda, mucosal immunity, nasal therapy, Anu Taila, integrative medicine